Clinical Evaluation of Abiraterone in the Treatment of Metastatic Prostate Cancer

Treatment of castration-resistant prostate cancer remains an area of unmet medical need. Evidence suggests that this entity continues to be driven by androgens and androgen receptor (AR) signaling. Abiraterone acetate, a pregnenolone derivative, is an oral selective and irreversible inhibitor of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Jatinder, Antonarakis, Emmanuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904375/
https://www.ncbi.nlm.nih.gov/pubmed/24482578
http://dx.doi.org/10.4137/CMU.S8337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904375/
https://www.ncbi.nlm.nih.gov/pubmed/24482578
http://dx.doi.org/10.4137/CMU.S8337

Ejemplares similares